AstraZeneca's lower EU vaccine supply target hinges on factory approval: Source
WorldFILE PHOTO: A test tube labelled"vaccine" in front of an AstraZeneca logo in this illustration taken on Sep 9, 2020. (Photo: REUTERS/Dado Ruvic)13 Mar 2021 10:10PMShare this contentBookmarkBRUSSELS: AstraZeneca's new aim of supplying 30 million doses of its COVID-19 vaccine to the European Union by the end March hinges on the bloc's drug regulator approving supplies from a factory in the Netherlands, an internal document showed.
The Anglo-Swedish drugmaker said on Friday (Mar 12) it would try to deliver 30 million doses to the EU by the end of March, down from a contractual obligation of 90 million and a previous pledge made last month to deliver 40 million doses.Advertisement
AdvertisementThe new lower target for March deliveries, which confirmed an earlier report from Reuters, depends on the regulatory approval of a vaccine factory in Leiden run by subcontractor Halix, the internal document dated Mar 10 showed.EU leaders have come under fire for rolling out vaccines at a far slower pace than neighbouring Britain due to a longer approval and purchasing process as well as repeated delays in supplies from AstraZeneca and other drugmakers. headtopics.com
AstraZeneca said in the document seen by Reuters that it is assuming the Halix factory will get the green light on Mar 25 and has pencilled in deliveries of nearly 10 million doses for the following week.The European Medicines Agency (EMA) confirmed in a statement that the Halix factory had not yet been approved and declined to comment on when any authorisation might be granted.Read more: CNA »
2 influencers face deportation from Bali over painted-on face mask prank
AstraZeneca further cuts EU vaccine supply target to 30 millionAstraZeneca cut its supply forecast of COVID-19 vaccine to the European Union in the first quarter to about 30 million doses, a third of its ...
Exclusive: EU blocks 3.1 million doses of AstraZeneca shots to Australia - sourceThe European Union has blocked shipments of 3.1 million doses of AstraZeneca's COVID-19 vaccine to Australia and the country has little hope of getting the remaining 400,000 doses it has been pledged on time, a government source said on Tuesday. The export curb underscores massive shortfalls of the AstraZeneca shot across the EU bloc and complicates Australia's inoculation campaign, which is already 83% behind its original schedule.
EU sues AstraZeneca over COVID-19 vaccine delivery shortfallBRUSSELS: The European Union said Monday (Apr 26) it has launched legal action against pharmaceutical giant AstraZeneca over coronavirus vaccine ...
EU regulator declares AstraZeneca vaccine 'safe and effective'The review from the medicines regulator comes after a string of European countries suspended their rollouts of the vaccine after fears it caused blood clotting.
EU regulator 'firmly convinced' AstraZeneca jab benefits outweigh risksGENEVA — The EU's medicines regulator said Tuesday (March 16) it was
How the EU and AstraZeneca ended up in court, and what nextThe European Commission has launched legal proceedings against Anglo-Swedish drugmaker AstraZeneca for not respecting its contract for the supply ...